Group One Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Group One Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$4K	–	9148
2021 Q3	$4K	Buy	+200	New	+$5.52K	﹤0.01%	7846
2021 Q2	–	Sell	-1,500	Closed	-$38K	–	8786
2021 Q1	$38K	Buy	1,500 +1,200	+400%	+$30.6K	﹤0.01%	6415
2020 Q4	$7K	Sell	300 -105,000	-100%	-$2.31M	﹤0.01%	5942
2020 Q3	$1.89M	Buy	+105,300	New	+$2.18M	0.01%	1641
2018 Q2	–	Sell	-100	Closed	-$1K	–	5635
2018 Q1	$1K	Buy	+100	New	+$1.08K	﹤0.01%	4728

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Group One Trading's DRNA Position: Q2 2021 in Review

Group One Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 2,385 shares — an estimated $73.1K sold.

Group One Trading first reported a position in DRNA in Q3 2017 and held it in 3 quarters. The position peaked at $1.11M in Q3 2020. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

Group One Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Group One Trading sold 2,385 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $73.1K.
Group One Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
Group One Trading's Dicerna Pharmaceuticals, Inc. position peaked at $1.11M in Q3 2020.
203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.